An observational study in Non ST Segment Elevation Acute Coronary Syndrome, sponsored by National Research Center for Preventive Medicine. Completed at 1 site in Russian Federation. Per ClinicalTrials.gov, last updated 2023-12-11.
Sponsored by National Research Center for Preventive Medicine · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
To evaluate possibilities of rapid differential diagnosis and risk stratification in patients urgently admitted to the CCU with a suspected acute coronary syndrome without persistent ST-segment elevation (NSTEACS).
Single centre prospective non-randomised non-comparative study of patients delivered by ambulance and admitted to the CCU with suspected NSTEACS.
Aims of this study are:
National Research Center for Preventive Medicine is the lead sponsor of 18 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients delivered by ambulance and admitted to the CCU with suspected diagnosis "acute coronary syndrome (ACS)".
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients urgently admitted to the CCU with suspected NSTEACS
Diagnostic Test: Approaches to differential diagnosis and risk stratification
Detailed analysis of clinical course, ECG, biomarkers (hsTn I, CK-MB mass, myoglobin, NT-proBNP, hsCPR, cardiac FABP on admission and after 3 hours; hsTn I, CK-MB mass and myoglobin after 6 hours if needed) as well as HEART, ADAPT, EDACS, T-MACS, GRACE, ACTION and TIMI scores.
Clinical outcomes
Composite of death, (re) infarction, stroke or re-hospitalization
Time frame: 6 monts
Final diagnosis
Final diagnosis - the main reason for urgent hospitalization - according to hospital case history
Time frame: Up to 1 monts
Death
Death upon discharge and up to 6 months
Time frame: 6 months.
(re) infarction
(re) infarction upon discharge and up to 6 months
Time frame: Up to 1 monts
Stroke
Stroke upon discharge and up to 6 months
Time frame: 6 months.
Re-hospitalization
Recurrent hospital admissions after discharge form the index hospitalization
Time frame: 6 months.
Urgent revascularisation
Revascularisation performed due to sudden clinical deterioration
Time frame: Up to 1 monts
Other adverse events
All adverse events/complications not included in clinical outcomes end points.
Time frame: 6 months.
Plan to share: No
No publications or documents are linked to this record.
Ran from Mar 2020 to primary completion in Nov 2023, 44 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Research Center for Preventive Medicine